Analyst Consensus ?
ConsensusHold29 ratings
Bullish1448.3%
Neutral1344.8%
Bearish26.9%
1 unmapped firm rating excluded from the percentages.
The J. M. Smucker Company · SJM · FY2025 Q1 · Calendar Q3 2024
Smucker posts EPS beat as sales outlook is lowered
The current evidence is mixed for the growth thesis: Uncrustables, coffee pricing, and brand innovation support continued growth, while weaker snack categories, lowered comparable-sales guidance, higher coffee costs, and mildly dilutive Hostess contribution are meaningful offsets.
Reported Before market openNYSEConsumer Defensive
$13.57B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.44
Consensus $2.17
EPS surprise
+12.4%
Reported versus consensus
Reported revenue
$2.13B
Consensus $2.13B
Revenue surprise
-0.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-4.9%
Event window
SPY move
-0.6%
Same window
Abnormal move
-4.4%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
+4.5%
Up to 20 sessions
SJMSPY benchmark
Ask FN2 about SJM FY2025 Q1
Transcript, numbers and history already loaded
Why did SJM fall 4.9% after beating EPS estimates in FY2025 Q1?What changed in SJM's guidance and outlook in FY2025 Q1?Give me the bull and bear case for SJM after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the tone remains confident but the outlook is less favorable: full-year comparable-sales guidance was lowered, coffee inflation prompted further pricing actions, and Hostess is now described as mildly dilutive in the near term.
Guidance delta
Management lowered full-year comparable-sales guidance to a 9% midpoint, citing weakness in sweet baked and pet snack categories.
Key takeaways
- Q1 results showed volume and EPS growth, but the full-year comparable-sales outlook was lowered.
- Uncrustables remains a central growth priority, with a $1 billion fiscal 2026 revenue ambition and added Alabama capacity.
- Coffee pricing actions are intended to address green coffee inflation across the portfolio.
- Hostess integration remains a longer-term value driver, but its current outlook is mildly dilutive.
Management priorities
- Expand Uncrustables capacity and launch new flavors.
- Execute additional coffee price adjustments and manage green coffee inflation.
- Complete the Hostess integration and expand distribution.
- Increase marketing later in the year for Hostess and other key brands.
Follow SJM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$127.07Current
$100Low
$132.13Average
$165High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 16, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 27, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 27, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 27, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Jefferies | Buy | Buy | Maintain | Aug 19, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 10, 2026 |
| Stifel | Hold | Hold | Maintain | Apr 21, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Argus Research | Hold | Buy | Downgrade | Sep 12, 2025 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 28, 2025 |
| Citigroup | Buy | Buy | Maintain | Jun 11, 2025 |
| Consumer Edge Research | Equal Weight | Underweight | Upgrade | Sep 1, 2023 |
| Exane BNP Paribas | Underperform | Underperform | Maintain | Nov 15, 2022 |
| Goldman Sachs | Sell | Sell | Maintain | Oct 10, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 24, 2022 |
| Guggenheim | Buy | Neutral | Upgrade | Nov 9, 2021 |
| Argus | Hold | Hold | Maintain | Apr 1, 2019 |
| Susquehanna | Positive | Neutral | Upgrade | Nov 13, 2017 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Jul 19, 2017 |
| Hilliard Lyons | Neutral | Upgrade | Jul 11, 2017 | |
| Bank of America | Neutral | Neutral | Maintain | Dec 6, 2016 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | May 26, 2016 |
| Tigress Financial | Buy | Buy | Maintain | Sep 10, 2015 |
| Northcoast Research | Buy | Neutral | Upgrade | Sep 12, 2013 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jun 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $127.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Andrew Lazar | $137 | $125.93 | +7.8% | Oct 16, 2026 |
| Bernstein | Analyst unavailable | $160 | $121.84 | +25.9% | Oct 15, 2026 |
| Coker Palmer | Thomas Palmer | $149 | $132.44 | +17.3% | Aug 27, 2026 |
| RBC Capital | Analyst unavailable | $150 | $131 | +18.0% | Aug 27, 2026 |
| Evercore ISI | David Palmer | $150 | $130.9 | +18.0% | Aug 27, 2026 |
| Bernstein | Analyst unavailable | $157 | $130.9 | +23.6% | Aug 27, 2026 |
| Wells Fargo | Analyst unavailable | $144 | $130.9 | +13.3% | Aug 27, 2026 |
| Barclays | Analyst unavailable | $145 | $130.9 | +14.1% | Aug 27, 2026 |
| Stifel Nicolaus | Matthew Smith | $132 | $130.9 | +3.9% | Aug 27, 2026 |
| Deutsche Bank | Analyst unavailable | $125 | $130.9 | -1.6% | Aug 27, 2026 |
| UBS | Peter Grom | $142 | $122.84 | +11.7% | Aug 20, 2026 |
| Jefferies | Analyst unavailable | $140 | $118.5 | +10.2% | Aug 19, 2026 |
| H.C. Wainwright | Analyst unavailable | $123 | $118.5 | -3.2% | Aug 19, 2026 |
| Deutsche Bank | Steve Powers | $107 | $120.33 | -15.8% | Aug 14, 2026 |
| Evercore ISI | Analyst unavailable | $125 | $116.48 | -1.6% | Jul 23, 2026 |
| UBS | Analyst unavailable | $130 | $116.66 | +2.3% | Jun 11, 2026 |
| Barclays | Analyst unavailable | $125 | $117.05 | -1.6% | Jun 11, 2026 |
| Bernstein | Alexia Howard | $137 | $115.78 | +7.8% | Jun 10, 2026 |
| Wells Fargo | Analyst unavailable | $115 | $112.39 | -9.5% | Jun 10, 2026 |
| BTIG | Analyst unavailable | $130 | $112.39 | +2.3% | Jun 10, 2026 |
| Coker Palmer | Thomas Palmer | $125 | $112.39 | -1.6% | Jun 10, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $110 | $112.39 | -13.4% | Jun 10, 2026 |
| RBC Capital | Nik Modi | $135 | $112.39 | +6.2% | Jun 10, 2026 |
| RBC Capital | Analyst unavailable | $132 | $112.39 | +3.9% | Jun 10, 2026 |
| Morgan Stanley | Analyst unavailable | $106 | $101.12 | -16.6% | Jun 5, 2026 |
| Deutsche Bank | Steve Powers | $95 | $100.38 | -25.2% | May 20, 2026 |
| Evercore ISI | Analyst unavailable | $117 | $99.58 | -7.9% | May 15, 2026 |
| Bernstein | Analyst unavailable | $134 | $96.97 | +5.5% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $104 | $94.99 | -18.2% | Apr 23, 2026 |
| Stifel Nicolaus | Analyst unavailable | $100 | $96.14 | -21.3% | Apr 21, 2026 |
| Barclays | Analyst unavailable | $103 | $91.04 | -18.9% | Apr 14, 2026 |
| BTIG | Rob Dickerson | $120 | $89.53 | -5.6% | Apr 13, 2026 |
| BNP Paribas | Analyst unavailable | $125 | $92.47 | -1.6% | Apr 9, 2026 |
| Wells Fargo | Chris Carey | $125 | $93.79 | -1.6% | Apr 8, 2026 |
| Morgan Stanley | Megan Clapp | $105 | $104.78 | -17.4% | Jan 16, 2026 |
| UBS | Peter Grom | $117 | $100.38 | -7.9% | Nov 26, 2025 |
| Morgan Stanley | Analyst unavailable | $115 | $100.38 | -9.5% | Nov 26, 2025 |
| Bernstein | Analyst unavailable | $113 | $100.38 | -11.1% | Nov 26, 2025 |
| Stifel Nicolaus | Analyst unavailable | $110 | $100.38 | -13.4% | Nov 26, 2025 |
| UBS | Peter Grom | $120 | $103.61 | -5.6% | Nov 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $115 | $102.59 | -9.5% | Oct 24, 2025 |
| UBS | Analyst unavailable | $121 | $106.72 | -4.8% | Aug 28, 2025 |
| D.A. Davidson | Analyst unavailable | $112 | $106.72 | -11.9% | Aug 28, 2025 |
| Stifel Nicolaus | Matthew Smith | $120 | $94.41 | -5.6% | Jun 10, 2025 |
| Barclays | Analyst unavailable | $119 | $112.09 | -6.4% | Mar 3, 2025 |
| Jefferies | Rob Dickerson | $116 | $118.46 | -8.7% | Nov 18, 2024 |
| Barclays | Andrew Lazar | $121 | $113.79 | -4.8% | Aug 30, 2024 |
| Coker Palmer | Thomas Palmer | $136 | $113.79 | +7.0% | Aug 29, 2024 |
| Citigroup | Thomas Palmer | $138 | $120.93 | +8.6% | Aug 20, 2024 |
| Argus Research | Taylor Conrad | $135 | $110.13 | +6.2% | Jun 13, 2024 |
| Bernstein | Alexia Howard | $121 | $115 | -4.8% | Jun 7, 2024 |
| Coker Palmer | Thomas Palmer | $139 | $115.37 | +9.4% | Jun 6, 2024 |
| CFRA | Arun Sundaram | $131 | $115.43 | +3.1% | Jun 6, 2024 |
| Wells Fargo | Michael Kaye | $140 | $116.42 | +10.2% | Jun 6, 2024 |
| Goldman Sachs | Ken Goldman | $128 | $116.94 | +0.7% | Jun 6, 2024 |
| Stifel Nicolaus | Matthew Smith | $135 | $116.94 | +6.2% | Jun 6, 2024 |
| Coker Palmer | Thomas Palmer | $137 | $116.94 | +7.8% | Jun 6, 2024 |
| Jefferies | Rob Dickerson | $121 | $110.4 | -4.8% | May 23, 2024 |
| Deutsche Bank | Faiza Alwy | $129 | $115.21 | +1.5% | May 20, 2024 |
| Goldman Sachs | Jason English | $131 | $116.35 | +3.1% | Dec 5, 2023 |
| Deutsche Bank | Steve Powers | $153 | $140.4 | +20.4% | Sep 8, 2023 |
| Morgan Stanley | Pamela Kaufman | $158 | $155.82 | +24.3% | Dec 20, 2022 |
| Credit Suisse | Robert Moskow | $165 | $154.27 | +29.8% | Dec 15, 2022 |
| Stifel Nicolaus | Christopher Growe | $155 | $154.17 | +22.0% | Dec 15, 2022 |
| Deutsche Bank | Faiza Alwy | $131 | $122.22 | +3.1% | Jun 20, 2022 |
| Citigroup | Wendy Nicholson | $131 | $130.7 | +3.1% | Mar 2, 2022 |
| Bernstein | Alexia Howard | $114 | $131.34 | -10.3% | Nov 24, 2021 |
| Barclays | Andrew Lazar | $140 | $131.34 | +10.2% | Nov 24, 2021 |
| Stifel Nicolaus | Christopher Growe | $136 | $132.66 | +7.0% | Nov 23, 2021 |
Track every rating change on SJM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe J. M. Smucker Company is an international enterprise specializing in the production and marketing of a diverse portfolio of branded food and beverage items. Its operations are organized into three principal U.S. retail divisions: Pet Foods, Coffee, and Consumer Foods. The company's extensive product offerings encompass various coffee options, including roast, ground, single-serve, and premium blends; a wide selection of spreads such as peanut butter and fruit preserves; cooking staples like shortening and oils; convenient frozen sandwiches and snacks; and a full range of pet food and treats.…
Historical context
All SJM earningsLatest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the SJM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-20T04:10:39.628060+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T04:10:39.625211+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.